A new era of metalbased drugs started in the 1960s, heralded by the discovery of potent platinumbased complexes, commencing with cisplatin h. Interest in the field has been promoted by the clinical use of a number of precious metal complexes, including platinum anticancer, gold antiarthritis and silver antibacterial agents. Inorganic and organometallic transition metal complexes. Some uses of transition metal complexes as anticancer and. Metallotherapeutic drugs and metalbased diagnostic agents. Ruthenium based anticancer drugs and their biochemistry is explained. On the medicinal chemistry of gold complexes as anticancer.
The hydroxyferrocifens consist of ferrocene linked to the active metabolite of tamoxifen, a breast cancer drug which targets the oestrogen receptor er, the aim being to combine the antioestrogen effect of tamoxifen with the cytotoxic properties of metal complexes. Research has shown significant progress in utilization of transition metal complexes as drugs to treat several human diseases. The quest for alternative drugs tothe wellknown cisplatin and its derivatives, which are still used in more than 50% of the treatment regimes for patients suffering from cancer, is. Introduction ruthenium complexes that mimic platinum drugs design of new anti. Synthesis of new platinumbased anticancer drugs yasser saud. This prototypical anticancer drug remains one of the most effective chemotherapeutic agents in clinical use. This timeliness has not diminished during the gestation and final publica tion of the manuscript.
Among chemotherapeutics, anti cancer metal drugs have enjoyed a long and successful history since the discovery of the benchmark cisplatin. The solid tumors were induced by subcutaneous sc injection of ehrlich ascites carcinoma eac cells in mice. Holler platinum complexes with specific activity against hormonedependent tumors e. Advances in metal drug discovery have motivated chemists to build plethora of complex structures. The therapeutic use of metal complexes in cancer and leukemia are reported from the sixteenth century. Metal based anticancer agents covers the interdisciplinary world of inorganic drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing emerging. To evaluate the in vivo anticancer activities of these complexes, the ligand 1 and its metal complexes 2, 7 and 9 were tested against solid tumors. Nsubstituted thiosemicarazone derivatives of acetyl pyridine, imino pyridine. Copper complexes as anticancer agents bentham science. The metal ionbase interaction depends on the nature of both metal and bases.
Full text metal complexes in cancer therapy an update. Summary offering an authoritative and timely account by twentynine internationally recognized experts, metal ions in biological systems. The impact of the selected complexes on the reduction of tumor volume was determined. Current interest in cu complexes is stemming from their potential use as antimicrobial, antiviral, antiinflammatory, antitumor agents, enzyme inhibitors, or chemical nucleases. Novel metals and metal complexes as platforms for cancer. Metalbased antitumor drugs play a relevant role in antiblastic chemotherapy. Many cytotoxic metal complexes target dna because of its importance in replication and cell viability. From the foregoing and, more importantly, from the contents of the various chapters, the reader will gain an appreciation of the very real role metalbased drugs play in modern medicine and of the considerable effort being devoted to the development of novel complexes with greater efficacy as therapeutic and diagnostic agents. Inorganic and organometallic transition metal complexes with biological molecules and living cells provides a complete overview of this important research area that is perfect for both newcomers and expert researchers in the field. Advances in metaldrug discovery have motivated chemists to build plethora of complex structures.
Some of the platinumbased antitumor drugs like cisplatin, carboplatin and oxaliplatin, have several disadvantages including side effects, cisplatinresistant tumors, limited solubility in aqueous media, and so on. The chapter highlights platinumii complexes as anti cancer drugs. The discovery of cisplatin, cispt ii nh 3 2 cl 2, was a defining moment which triggered the interest in platinumii and other metal containing complexes as potential novel anticancer drugs. Platinum ii complexes has been used as anti cancer drugs since long, among them cisplatin has proven to be a highly effective chemotherapeutic agent for treating various types of cancers1.
In the past, metalbased compounds were widely used in the treatment of disease conditions, but the lack of clear. One of the most successful is cisdiamminedichloroplatinumii, which is an active anti tumor agent at low concentration. Metal based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is regarded as one of the most effective drugs, even if severe toxicities and drug resistance phenomena limit its clinical use. When metals are scarce or high quantities, equilibrium is set out of balance and must be returned to its natural state via interventional and natural methods. Current interest in cu complexes is stemming from their potential use as antimicrobial, antiviral, anti inflammatory, antitumor agents, enzyme inhibitors, or chemical nucleases. Ruthenium has numerous properties that qualify it as an antineoplastic drug contender. This prototypical anticancer drug remains one of the most effective chemotherapeutic agents in. Metals in medicine are used in organic systems for diagnostic and treatment purposes. Notable is the wide variation in target sites, dependent on the metal, its oxidation state, the types and numbers of coordinated ligands.
Metal complexes in tumor diagnosis and as anticancer agents is devoted solely to the vital research area concerning metal complexes in cancer diagnosis and therapy. Platinum complexes which are most studied metal complexes due to their importance as adjuvant therapy of cancers aiming to induce tumorcelldeath. Due to the diversity of coordination number and molecular geometry a metal center can assume, the metal complexes structure and applicability are likewise diverse, e. Preventing spread of cancer with copper molecules date. One simple metal complex revolutionised the treatment of cancer in the latter half of the 20th century. Among chemotherapeutics, anticancer metaldrugs have enjoyed a long and successful history since the discovery of the benchmark cisplatin. Polynuclear polyamine complexes, in particular, have attracted special attention, since they were found to yield dna adducts not available to conventional drugs through longdistance intra and interstrand crosslinks and to. Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. Cisplatin is also one of the anticancer drugs that most frequently induce nausea, vomiting, and diarrhea. Due to their reactivity, metals are tightly regulated under normal conditions and aberrant metal ion concentrations are associated with various pathological disorders, including cancer. However, the platinum based treatment of tumoral diseases is massively hampered by severe side effects and resistance development. Novel metals and metal complexes as platforms for cancer therapy.
Since the introduction of cisplatin to oncology in 1978, ptii and pdii compounds have been intensively studied with a view to develop the improved anticancer agents. Porphyrinfe transition metal complex feii ion is octahedrally coordinated coordination number 6 haemoglobin n n n n ho 2c ho 2c fe nr n n n n ho2c ho2c fe nr o 2 cisplatin ptcl 2nh 3 2 square planar ptii coordination number 4 cisisomer the first of a series of platinum coordination complexbased anticancer drugs platinolaq. The use of metals and their salts for medicinal purposes, from iatrochemistry to modern day, has been present throughout human history. Many metal coordination complexes have been investigated as potential anticancer drugs with a rich diversity of effects and toxicity 1. Saur mechanism of action of tumorinhibiting metal complexes e. Cisplatin, as one of the leading metalbased drugs, is widely used in the treatment of cancer. Platinum antitumor complexes the potential of metalbased anticancer agents has only been fully realized and explored since the landmark discovery of the biological activity of cisplatin cisdiamminedichloroplatinumii or cisddp. We have summarized some recent advances in the design of organometallic anticancer complexes. While platinumbased compounds have served as very successful anti cancer drugs, they have several limitations including their side effects, as well as ineffectiveness against certain types of cancer. Markedly, the biochemical action of cu complexes with nonsteroidal antiinflammatory drugs nsaids has been studied.
Reaction mechanisms of metal complexes sciencedirect. Preventing spread of cancer with copper molecules sciencedaily. Now a useful new addition to the literature has been published, somewhat oddly, as volume 11 in the series catalysis by metal complexes. Synthesis, characterization, and in vivo anticancer activity. Heim provisions for international approval of metal complexes in anti cancer therapy f. One of the most successful is cisdiamminedichloroplatinumii, which is an active antitumor agent at low concentration. Advances in the design of organometallic anticancer complexes. Transition metal complexes as drugs and chemotherapeutic. Some of the platinum complexes such as cisplatin, carboplatin, and oxaliplatin are the fdaapproved members of the platinum anticancer drug family. Cisplatin is also one of the anti cancer drugs that most frequently induce nausea, vomiting, and diarrhea. Platinum and palladium polyamine complexes as anticancer.
Therefore, pdii complexes are too reactive, but ruii complexes have suitable substitution rates and some of these complexes have been shown to display interesting antitumor activity. Cisplatin, as one of the leading metal based drugs, is widely used in the treatment of cancer. Let us now take a step backwards in time, to the discovery of platinumbased anticancer drugs that revolutionised the treatment of cancers. Inorganic elements are also essential for organic life as cofactors in enzymes called metalloproteins.
Her research interest is focused on the synthesis of functional polymers with complex architectures such as glycopolymers and other polymers for biomedical applications, especially polymers with inbuild metal complexes for the delivery of metal based anti cancer drugs. This chapter introduces three broad aspects of metals in medicine. Transition metal complexes and their application in drugs and. Different treatments have been applied to kill cancer cells such as chemotherapy, which is the use of chemicals or drugs in order to treat cancer cells. Many complexes containing a variety of amines have been synthesized. Western michigan university, 2015 cancer is considered the second leading cause of death after heart attack. Many metal coordination complexes have been investigated as potential anti cancer drugs with a rich diversity of effects and toxicity 1. Let us now take a step backwards in time, to the discovery of platinumbased anti cancer drugs that revolutionised the treatment of cancers. Apoptosisinducing oxovanadiumiv complexes of 1,10phenanthroline against human ovarian cancer. Metal based anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of selected platinum and arsenic compounds to patients. Viva voce examination university of madras interaction of copperii complexes of bi and tridentate ligands with dna and their antiproliferative effects on osteosarcoma cancer cell s rajalakshmi chemical laboratory. This perspective covers the recent contributions of the che laboratory to the development of transitionmetalbased anticancer complexes, including gold, platinum, ruthenium and iron complexes. Transition metal complexes and their application in drugs. Numerous examples of complexes based on different metals such as ruthenium, osmium, titanium, and gold, have shown potential as active agents or as prodrugs in anticancer therapy, for example, ruthenium polypyridyl complexes, gold nheterocyclyc carbenes, ptpd phosphorus ylides, and schiff base complexes.
Heim provisions for international approval of metal complexes in anticancer therapy f. Some use of transition metal complexes as anticancer and antihiv agents. A new era of metal based drugs started in the 1960s, heralded by the discovery of potent platinumbased complexes, commencing with cisplatin h. Exactly how they worked was the subject of study for many years, and was finally deduced by steve lippard mit and amy rosenzweig northwestern. Interdisciplinary in approach, the book covers both clinical and experimental aspects of the subject. When this book was first conceived as a project the expanding interest in the clinical use of platinum and gold complexes made a survey of the relevant biological properties of metal complexes timely and appropriate. For these reasons, coordination complexes, either as drugs or prodrugs, become very attractive probes as potential anticancer agents. Metal complexes have shown interesting preclinical and clinical results as antitumor drugs and platinum compounds are well established in current cancer chemotherapy. Though most ruthenium complexes are only in the beginning stages of the approval process for anticancer drugs, many of their properties may give them advantages over many platinumbased drugs now in use. One of the most notable successes for inorganic drugs has been the effectiveness of platinum complexes against. Platinum antitumor complexes the potential of metal based anticancer agents has only been fully realized and explored since the landmark discovery of the biological activity of cisplatin cisdiamminedichloroplatinumii or cisddp.
Metal complexes in cancer therapy an update from drug design perspective umar ndagi, ndumiso mhlongo, mahmoud e soliman molecular modelling and drug design research group, school of health sciences, university of kwazulunatal, westville, durban, south africa abstract. Through concise chapters written and edited by esteemed experts, this book brings together a comprehensive. Platinum metal complexes in medicine sponsored chemistry. In 1960 an inorganic complex cisplatin was discovered, today more than 50 years, it is still one of the worlds best selling anticancer drug. This book presents a critical overview of the present status of metal complexes in cancer chemotherapy. Metal complexes in cancer treatment metal complexes have a higher position in medicinal chemistry. Significant side effects and drug resistance, however, have limited its clinical applications.
A number of platinumii complexes are important anti cancer drugs. Metalbased anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of selected platinum and arsenic compounds to patients. Mar 02, 2015 preventing spread of cancer with copper molecules date. Synthesis of novel platinum complexes showing potential as. Metal complexes as potential imaging agents and anticancer drugs. Organometallic complexes can act as biocatalysts for modulating the redox state of cancer cells. Metal complexes in cancer therapy an update from drug. New trends for metal complexes with anticancer activity. Problem p is a member of a class of potent anticancer drugs that are particularly effective against testicular and ovarian tumours. Coordination compounds offer many binding modes to polynucleotides, including outersphere noncovalent binding, metal coordination to nucleobase and phosphate backbone 810 metal complexes as drugs and chemotherapeutic agents. Giuseppe sciortino, eugenio garribba, jeandidier marechal. Gold coordination complexes as anticancer agents bentham.
767 975 1173 1604 282 155 699 923 1089 1389 944 798 640 988 160 1263 1291 142 1329 868 1158 1461 801 188 1280 1419 1418 427 12 711 1432 441 315 471